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Abstract
Introduction. Yolk sac tumors represent only 5%–7% of
intracranial germ cell tumors, which comprise about 1% of
all  primary brain tumors in adults. Literature data about
nonspecific imaging characteristics of these tumors are
scant. We presented magnetic resonance imaging findings
with diffusion-weighted imaging and proton magnetic reso-
nance spectroscopy of this rare type of tumor in an adult
patient. Case report. A 55-year-old man with progressive
left side weakness, headache, dizziness and ataxia, under-
went preoperative magnetic resonance imaging, diffusion-
weighted imaging and proton magnetic resonance spectros-
copy. After surgical resection and histological analysis, the
final diagnosis of yolk sac tumor was established. Retro-
spective imaging analysis were performed in order to de-
termine imaging and biochemical parameters that could be
useful in the diagnostic evaluation of this tumor type. Con-
clusion. Though the imaging features of yolk sac tumor are
not specific, morphoanatomical and metabolic imaging
could offer the information that provides new insights into
this tumor that may facilitate further therapeutic decision
process and potentially provides better information regard-
ing the disease prognosis.
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Apstrakt
Uvod. Tumori porekla žumančane kese (yolk sac tumori)
predstavljaju samo 5–7% intrakranijalnih tumora porekla iz
germinativnih ćelija, koji čine oko 1% svih primarnih tumo-
ra mozga kod odraslih. Podaci iz literature o nespecifičnim
karakteristikama ovih tumora na snimku su oskudni. Prika-
zali smo nalaz magnetne rezonancije sa difuzionim snima-
njem i protonskom magnetno-rezonantnom spektroskopi-
jom ovog retkog oblika tumora kod odraslog bolesnika.
Prikaz bolesnika. Bolesnik, star 55 godina, sa progresiv-
nom levostranom slabošću, glavoboljom, vrtoglavicom i
ataksijom, preoperativno je podvrgnut magnetnoj rezonan-
ciji, difuzionom snimanju i protonskoj magnetno rezonant-
noj spektroskopiji. Nakon hirurške intervencije i histološke
analize, postavljena je konačna dijagnoza yolk sac tumora.
Retrospektivna analiza snimanja sprovedena je sa ciljem od-
ređivanja parametara snimanja kao i biohemijskih parameta-
ra koji mogu biti korisni u dijagnostičkoj proceni ovog tipa
tumora. Zaključak. Iako su karakteristike snimka yolk sac
tumora nespecifične, morfoanatomsko i metaboličko sni-
manje može pružiti informacije koje daju novi uvid u ovu
vrstu tumora, i time olakšati budući proces donošenja tera-
pijske odluke. Osim toga, ono potencijalno obezbeđuje pre-
ciznije informacije, što je značajno za prognozu bolesti.
Ključne reči:
mozak, neoplazme; endodermalni sinus tumor;
dijagnoza; dijagnostičke tehnike i procedure;
magnetna rezonanca, snimanje; magnetna rezonanca,
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Introduction
Yolk sac tumors (YST) represent only 5%–7% of intra-
cranial germ cell tumors (GCT), which comprise about 1%
of all  primary brain tumors in adults and 3%–8% of
all primary brain tumors in children. The peak incidence of
intracranial GCT is between 10 and 14 years, 95% of them
occurring before the age of 35 
1–5. Based on literature data,
there are only two previously reported cases of patients with
intracranial GCT elder than 45 years.
Since radiological appearance can be nonspecific and
literature data of these tumors are scant, differentiation of
YST from other neoplasms may be difficult. Conventional
magnetic resonance imaging (MRI) with advanced MRI
techniques, such as magnetic resonance diffusion [diffusion-
weighted imaging (DWI) and proton magnetic resonance
spectroscopy (
1H MRS)], can provide additional information
to improve tumor characterization.
We reported the second case of YST and the third case
of all intracranial GCT diagnosis in a 55-year-old patient
using conventional MRI with DWI and 
1H MRS.
Case report
A 55-year-old man, was originally presented in March
2009, with a few-weeks history of progressive left side
weakness, headache, dizziness and ataxia. Brain computed
tomography (CT) scan showed expansive lesion with the lo-
calization on the right side of mesencephalon and cerebral
peduncle. MRI revealed an expansive ovoid mass, 35  23 
27 mm in size, localized in the region of the dorsal thalamus,
cerebral peduncle, tegmentum mesencephali and ventral and
proximal aspect of pons, dominantly on the right side. The
tumor showed compression on the ventricle III and me-
diosagital structures with mild perifocal edema (Figure 1).
The mass showed as heterogeneous, hypo- to isointense with
hiperintense rim on T2-weighted (Figure 1a) and fluid-
attenuated inversion-recovery (FLAIR), and hypointense
with hiperintense focus on T1-weighted images (Figure 1b).
The lesion displayed discretely enhancement (Figures 1c, d).
DWI with calculated apparent diffusion coefficient (ADC)
map revealed facilitated diffusion (1.44  10
-3 mm
2 sec
-1) in
the enhanced component of the lesion (Figure 2a). Mul-
tivoxel 
1H MRS with short echo time (TE = 30 ms) and se-
lected voxel (Figures 2b, d) positioned in the rim of the le-
sion showed increased choline/creatine (Cho/Cr), decreased
N-acetylaspartate/Cr (NAA/Cr) ratio and the presence of
prominent lipid peak (Figures 2c, d). The radiological differ-
ential diagnosis included central nervous system (CNS) lym-
phoma and germinoma. Since the diagnosis of GCT was sus-
pected, α-fetoprotein (AFP) and β-human chorionic gonado-
tropin (β-HCG) levels were checked preoperatively in the se-
rum and cerebrospinal fluid (CSF). Laboratory tests showed
normal values of AFP β-HCG in the serum (AFP: 7,46
ng/mL; β-HCG: 0,01 mIU/mL), and in the CSF (AFP: 0,56
ng/mL; β-HCG: 2,15 mIU/mL). Based on the extent of the
lesion, no surgery was applied. Since biochemical analysis
was negative, the patient underwent biopsy of the tumor in
Fig. 1 – Tumor occupies dorsal thalamus, cerebral
peduncle, mesencephalic tegmentum and pons with
compromitation of third ventricle and adjacent structures
Axial T2-weighted image (b) Axial T1-weighted image (c)
Axial T1-weighted postcontrast image (d) Coronal T1-
weighted postcontrast image
Fig. 2 – (a) Apparent diffusion coefficient (ADC) map
with measured high ADC value; (b) One voxel from
chemical shift imaging (CSI) position in the rim of the
lesion, corresponding to an area of maximal
choline/creatine (Cho/Cr) ratio; (c) Color map of CSI
spectrum showing area of maximal Cho/Cr ratio with red
color; (d) Spectrum from voxel corresponding to an area of
maximal Cho/Cr ratio showing a marked decrease in N-
acetylaspartate, increase in Cho and prominent lipids
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April 2009. Histological examination with immunohisto-
chemistry showed polymorphic tumor proliferation, con-
sisted of primitive epithelial cells, with isolated giant cells
and hyaline globules within loose myxoid matrix (Figure 3a).
The epithelial component of the tumor showed characteristic
cytoplasmatic immunolabeling for AFP (Figure 3b). Since
patient health status deteriorated, control brain CT and MRI
were performed. Imaging findings showed progression of the
lesion and the presence of hydrocephalus. A CSF shunt sys-
tem was implanted, and antiedematose and hemiotherapy
were introduced (CDDP Cisplatin, 35 mg). Five days after
hemiotherapy, health state of the patient deteriorated for the
second time and cardiac arrest emerged.
Fig. 3 – (a) Polymorphism, primitive appearing
epithelial cells and hyaline globules in yolk sac tumor (YST)
(HE  20); (b) the alpha fetoprotein (AFP) cytoplasmatic
immunolabeling of YST epithelial component (AFP  20)
Discussion
The World Health Organization classificated intracra-
nial GCT as: germinomas, embryonal carcinomas, YST (s.
endodermal sinus tumors), choriocarcinomas, teratomas
(mature and immature), teratomas with malignant transfor-
mation and mixed germ cell tumors 
2. Intracranial GCT
comprises about 1% of all primary brain tumors in adults 
2–7
and 3%–8% of all  primary brain tumors in children 
8–12.
Among all primary intracranial GCT, the most common his-
tological types are germinomas (60%), while YST represent
only 5%–7% of these tumors 
2, 5. Тhe peak incidence of in-
tracranial GCT is between 10 and 14 years, and almost 95%
of these tumors occur before the age of 35 
1–5. Although the
vast majority of cases are diagnosed in young children, there
have been isolated case reports in adults. Kirikae et al. 
13 re-
ported the eldest patient with intracranial GCT who was a
65-year-old man with YST. Park and al. 
14 reported a 47-
year-old woman with intracranial mature teratoma. Based on
literature data, our case is the second one with YST and the
third one of all intracranial GCT in a patient elder than 45
years.
The biochemical assessment of intracranial GCT serves
as an accepted method for initial classification without tissue
sampling, while CSF cytology is an evidence of tumor dis-
semination into the neuroaxis 
14–17. Laboratory diagnosis of
GCT is based on tumor markers analysis in the serum and
CSF, and CSF cytology 
2, 3. The normal range of AFP in the
serum and CSF for adults is 0–15 ng/mL, and normal serum
and CSF β-HCG levels are less than 2,5 mIU/mL in men,
and less than 5,0 mIU/mL in non-pregnant women 
14–17. As-
sociated predominantly with YST, AFP can also be ex-
pressed by embryonic carcinomas and immature teratomas,
while β-HCG is markedly elevated in association with cho-
riocarcinomas and germinomas with the presence of syncy-
tiotrophoblastic giant cells 
14–17. Although YST is known to
be an AFP-producing tumor, our patient showed normal val-
ues of AFP. As in other cases, production of β-HCG was not
present in our case, too.
As typical for GCT, YST arises as midline tumors,
commonly localized in the pineal or suprasellar region 
5–11.
Since radiological manifestation can be nonspecific, espe-
cially in adults, differentiation of YST from other neoplasms
is difficult 
18, 19. Literature data of YST, especially about their
radiological appearance, are scant 
1, 2, 17, 18, 20–22. On MRI,
YST is usually shown as heterogeneous mass with foci of
calcification and cysts, and contrast enhancement 
1, 2. As in
our case, there are cases described with T1-weighted iso-
/hypointense and T2-weighted iso/hyperintense appearance
of these tumors 
20–23. MRI presentation of our case only con-
firms unspecific manifestation of YST. Based on conven-
tional MRI findings, differential diagnosis included primary
CNS lymphoma and germinoma. Advanced MR techniques
offered additional information which could improve tumor
characterization. Based on 
1H MRS lymphoma and germi-
noma were highly suspected. Like in lymphomas and germi-
nomas 
21, 
1H MRS of YST showed increased Cho/Cr, de-
creased NAA/Cr ratio and the presence of prominent lipid
peak. Since 
1H MRS of these tumors is very similar, useful-
ness of these findings was limited. Lipid resonances
may originate from mobile lipid molecules, based on tissue
degradation  and necrosis, or from B-lymphocytes, trans-
formed T-lymphocytes, cultured human leukemic lympho-
cytes and macrophages 
24. A strongly increased Cho/NAA
ratio and lipid resonances in the absence of necrotic area on
MRI, is suggestive for lymphocytes infiltration. However,
based on DWI, differential diagnosis can be made. DWI
evaluates size of extracellular space, cellularity and cyto-
plasm/extracellular space ratio 
25. Intracranial primary lym-
phomas show restrictive diffusion due to their hipercelullar-
ity 
2, 5, 21. Similar to lymphomas, germinomas demonstrate re-
strictive diffusion with low ADC values 
2, 5. Unlike lympho-
mas and germinomas, YST shows facilitated diffusion. This
information is important for MR diagnosis of YST, and con-
sequently for patient's therapeutic treatment and prognosis.
While germinomas are exquisitely radiosensitive, with a
5-year survival rates of roughly 90% with radiotherapy
alone, for other intracranial GCT neoadjuvant chemotherapy
is used in combination with radiotherapy and maximal surgi-
cal resection. YST, like most of other GCT, are associatedStrana 280 VOJNOSANITETSKI PREGLED Volumen 69, Broj 3
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with the poorest prognosis, with a 5-year survival rates in the
range of 9% to 49%, even with aggressive therapy 
2, 7, 15, 26, 27.
Conclusion
There are no specific imaging features of YST, but
DWI and 
1H MRS offer information that provides new in-
sights into these tumors, and may play the role in differen-
tiation from other neoplasms. Still, histological verifica-
tion remains necessary.
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